| Product NDC: | 0068-0037 |
| Proprietary Name: | Cantil |
| Non Proprietary Name: | mepenzolate bromide |
| Active Ingredient(s): | 25 mg/1 & nbsp; mepenzolate bromide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0068-0037 |
| Labeler Name: | sanofi-aventis U.S. LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA010679 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19561114 |
| Package NDC: | 0068-0037-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (0068-0037-01) |
| NDC Code | 0068-0037-01 |
| Proprietary Name | Cantil |
| Package Description | 100 TABLET in 1 BOTTLE (0068-0037-01) |
| Product NDC | 0068-0037 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | mepenzolate bromide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19561114 |
| Marketing Category Name | NDA |
| Labeler Name | sanofi-aventis U.S. LLC |
| Substance Name | MEPENZOLATE BROMIDE |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anticholinergic [EPC],Cholinergic Antagonists [MoA] |